


Searching News Database: ReFacto AF
HSMN NewsFeed - 7 Dec 2015
Syros Pharmaceuticals Appoints David A. Roth, M.D., as Chief Medical Officer
Syros Pharmaceuticals Appoints David A. Roth, M.D., as Chief Medical Officer
HSMN NewsFeed - 11 Mar 2009
European Commission Approves ReFacto AF(TM) as a Variation to the Refacto(R) Marketing Authorisation
European Commission Approves ReFacto AF(TM) as a Variation to the Refacto(R) Marketing Authorisation
